These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17657798)

  • 21. A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin.
    Lee WJ; Keefer K; Hollenbeak CS; Stack BC
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):466-71. PubMed ID: 15467619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.
    Mannello F
    Cancer; 2003 Jan; 97(1):201-3; author reply 203-4. PubMed ID: 12491521
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
    Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D; Siegel BA; McDonald DJ; Nussenbaum B
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of low-molecular fluorescent dyes for localizing tumor cells].
    Steven FS; Maier H; Born IA; Altmannsberger M
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(1):32-5. PubMed ID: 2102400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of matrix metalloproteinases type I expression and tumor front parameters in the presence of lymph node micrometastases in carcinoma of the larynx.
    Starska K; Łukomski M; Stasikowska O; Lewy-Trenda I
    Adv Med Sci; 2007; 52():169-73. PubMed ID: 18217412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
    Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
    In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays.
    Rickman DS; Millon R; De Reynies A; Thomas E; Wasylyk C; Muller D; Abecassis J; Wasylyk B
    Oncogene; 2008 Nov; 27(51):6607-22. PubMed ID: 18679425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased APN/CD13 and acid aminopeptidase activities in head and neck squamous cell carcinoma.
    Pérez I; Varona A; Blanco L; Gil J; Santaolalla F; Zabala A; Ibarguen AM; Irazusta J; Larrinaga G
    Head Neck; 2009 Oct; 31(10):1335-40. PubMed ID: 19373777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.
    Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S
    Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteases in head and neck cancer.
    Rosenthal EL; Matrisian LM
    Head Neck; 2006 Jul; 28(7):639-48. PubMed ID: 16470875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck.
    Werner JA; Rathcke IO; Mandic R
    Clin Exp Metastasis; 2002; 19(4):275-82. PubMed ID: 12090467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a new rat model of head and neck squamous cell carcinoma.
    Aubry K; Paraf F; Monteil J; Bessede JP; Rigaud M
    In Vivo; 2008; 22(4):403-8. PubMed ID: 18712164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.
    Heiduschka G; Erovic BM; Vormittag L; Skoda C; Martinek H; Brunner M; Ehrenberger K; Thurnher D
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):261-7. PubMed ID: 19289704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.